Charles Schwab
AH

Charles Schwab’s Accretive Health AH Stock Holding History

Charles Schwab’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-132,387
Closed -$1.21M – 3080
2013
Q4 		$1.21M Sell
132,387
-6,264
-5% -$53.9K ﹤0.01% 2176
2013
Q3 		$1.26M Buy
138,651
+2,161
+2% +$21.5K ﹤0.01% 2107
2013
Q2 		$1.51M Buy
+136,490
New +$1.44M ﹤0.01% 1925

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Charles Schwab's AH Position: Q1 2014 in Review

Charles Schwab sold out of Accretive Health (AH) in Q1 2014, closing a stake of 132,387 shares — an estimated $1.21M sold.

Charles Schwab first reported a position in AH in Q2 2013 and held it in 3 quarters. The position peaked at $1.51M in Q2 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

  • Charles Schwab reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
  • Charles Schwab sold 132,387 Accretive Health shares in Q1 2014, an estimated $1.21M.
  • Charles Schwab first reported a position in Accretive Health in Q2 2013 and held it in 3 quarters.
  • Charles Schwab's Accretive Health position peaked at $1.51M in Q2 2013.
  • 66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on Charles Schwab's 13F filing for Q1 2014, filed 29 Apr 2014.